SCHEMBL180479

SCHEMBL180479

O=P(O)(O)CCCCCCCCCCCO

nearest known ligand 0.61

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TYMS P04818 1/20 0.61
LPAR3 Q9UBY5 3/20 0.59
LPAR2 Q9HBW0 1/20 0.59
LMNA P02545 1/20 0.50
CYP3A4 P08684 1/20 0.50
NFKB1 P19838 1/20 0.50
BLM P54132 1/20 0.50
PMP22 Q01453 1/20 0.50
BBOX1 O75936 2/20 0.44
S1PR2 O95136 5/20 0.41
S1PR4 O95977 5/20 0.41
S1PR1 P21453 5/20 0.41
S1PR3 Q99500 5/20 0.41
S1PR5 Q9H228 1/20 0.41
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4534488 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4534884 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4533375 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4528349 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4535194 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4527268 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4528038 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4531101 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4528296 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4
SCHEMBL4517947 1.00 TYMS (0.61) TYMSLPAR3LPAR2LMNACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12527072-B2 Self-aligned patterning layer for metal gate formation TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2026-01-13 US claimed
US-20250014947-A1 SELF-ALIGNED PATTERNING LAYER FOR METAL GATE FORMATION TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD. (TW) 2025-01-09 US claimed
WO-2024237137-A1 QUANTUM DOT COMPOSITION, RESIN COMPOSITION, AND WAVELENGTH CONVERSION MATERIAL 信越化学工業株式会社 2024-11-21 WO claimed
WO-2024116801-A1 QUANTUM DOT COMPOSITION, RESIN COMPOSITION USING SAME AND WAVELENGTH CONVERSION MATERIAL 信越化学工業株式会社 2024-06-06 WO claimed
CN-113896924-B Metal glass modified release film 佛山市佳世达薄膜科技有限公司 2023-04-28 CN claimed
US-20230121929-A1 ELECTROCHEMICAL ATTACHMENT OF PHOSPHONIC ACIDS TO METALLIC SUBSTRATES AND ANTIMICROBIAL MEDICAL DEVICES CONTAINING SAME QUATSSANT, LLC 2023-04-20 US claimed
US-11540514-B2 Electrochemical attachment of phosphonic acids to metallic substrates and antimicrobial medical devices containing same MOLECULAR SURFACE TECHNOLOGIES, LLC (US) 2023-01-03 US claimed
EP-3990195-A1 ELECTROCHEMICAL ATTACHMENT OF PHOSPHONIC ACIDS TO METALLIC SUBSTRATES AND ANTIMICROBIAL MEDICAL DEVICES CONTAINING SAME Molecular Surface Technologies, LLC (US) 2022-05-04 EP claimed
CN-113896924-A Metal glass modified release film 佛山市佳世达薄膜科技有限公司 2022-01-07 CN claimed
US-20210213162-A1 METHODS OF PRODUCTION OF FIBROUS FIBRINOGEN SCAFFOLDS AND PRODUCTS THEREOF UNIVERSITÄT BREMEN (DE) 2021-07-15 US claimed
WO-2012100050-A1 A COMPOSITION FOR THE ATTACHMENT OF IMPLANTS TO COLLAGEN OR OTHER COMPONENTS OF BIOLOGICAL TISSUE NEW YORK SOCIETY FOR THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) 2012-07-26 WO claimed
US-20100034742-A1 MODULAR MONOLAYER COATINGS FOR SELECTIVE ATTACHMENT OF NANOPARTICLES TO BIOMOLECULES PRINCETON UNIVERSITY (US) 2010-02-11 US claimed
US-20100027192-A1 COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME GEORGIA TECH RESEARCH CORPORATION 2010-02-04 US claimed
WO-2010008826-A1 MODULAR MONOLAYER COATINGS FOR SELECTIVE ATTACHMENT OF NANOPARTICLES TO BIOMOLECULES PRINCETON UNIVERSITY (US) 2010-01-21 WO claimed
US-20080131709-A1 COMPOSITE STRUCTURE WITH ORGANOPHOSPHONATE ADHERENT LAYER AND METHOD OF PREPARING ACULON INC. (US) 2008-06-05 US claimed
WO-2008039959-A2 COMPOSITE STRUCTURE WITH ORGANOPHOSPHONATE ADHERENT LAYER AND METHOD OF PREPARING ACULON INC. (US) 2008-04-03 WO claimed
EP-1888311-A2 COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME GEORGIA TECH RESEARCH CORPORATION (US) 2008-02-20 EP claimed
US-20070077440-A1 Modified metal compositions, process for preparing the same, and biomaterials resistant to surface cell adhesion DUQUESNE UNIVERSITY OF THE HOLY SPIRIT 2007-04-05 US claimed
WO-2006124670-A2 COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME GEORGIA TECH RESEARCH CORPORATION (US) 2006-11-23 WO claimed
US-20040265571-A1 Surface-bonded, organic acid-based mono-layers PRINCETON UNIVERSITY (US) 2004-12-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100027192-A1 COATED METAL OXIDE NANOPARTICLES AND METHODS FOR PRODUCING SAME NCL, PNN, NCDN TYMS 3627/4885LPAR3 689/4885LPAR2 645/4885
US-20100034742-A1 MODULAR MONOLAYER COATINGS FOR SELECTIVE ATTACHMENT OF NANOPARTICLES TO BIOMOLECULES PHOSPHO1, EPCAM, EPHA2 TYMS 4379/4885LPAR3 991/4885LPAR2 1559/4885
US-20230121929-A1 ELECTROCHEMICAL ATTACHMENT OF PHOSPHONIC ACIDS TO METALLIC SUBSTRATES AND ANTIMICROBIAL MEDICAL DEVICES CONTAINING SAME PPM1A, PHOSPHO1, PPM1G TYMS 1760/4885LPAR3 3408/4885LPAR2 2542/4885
US-11540514-B2 Electrochemical attachment of phosphonic acids to metallic substrates and antimicrobial medical devices containing same PPM1A, PHOSPHO1, PPM1G TYMS 1760/4885LPAR3 3408/4885LPAR2 2542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.